WALTHAM, Massachusetts, January 12, 2016 /PRNewswire/ --
EarlySense®, the market leader in contact-free, health sensing and analytics, announced today year-end achievements for 2015, highlighted by key impact statistics.
In 2015, more than 84,000 patients around the world were monitored with the EarlySense Patient Monitoring System. Based on clinical data(*), it is estimated that the use of EarlySense has assisted clinicians in:
- Preventing 483 patient falls
- Preventing 2,070 pressure ulcers
- Saving 27,594 hospital days
- Saving 4,323 ICU days
- Preventing 415 Code Blue Events
- Saving 332 lives
Assuming that the financial analysis regarding cost savings published by Brigham and Women's Hospital researchers also applies, it is assumed that globally, healthcare facilities were able to save $18M in 2015.
"2015 was an extremely rewarding year for EarlySense as we doubled our installed base, thereby helping healthcare providers double the number of lives saved each year using the EarlySense System. In addition, increasing clinical evidence is showing the EarlySense System offers healthcare systems significant economic benefits," said Avner Halperin, CEO of EarlySense. "In fact, it has become typical that when a healthcare system acquires the EarlySense System, they almost always repurchase systems for additional care areas."
In 2015, EarlySense signed dozens of new customer facilities, including a VA Spinal Cord Injury (SCI) Center, which has been using EarlySense for more than one year, and has seen an 80% reduction in mortality following a 60% reduction of Code Blue activations.
This year, the company received regulatory clearance in South Korea and Canada. It also entered into partnerships with Mitsui to expand its presence in Japan and Custom Medical Solutions to increase its use in long term/home care facilities in the U.S. Most recently, the company entered into a co-marketing agreement with Herman-Miller Nemschoff that allows the first integrated chair with EarlySense sensors to be available in the market.
2015 also marked EarlySense's entry into the consumer wellness category, with the launch of its OEM solution, myEarlySense. The technology has already been incorporated into Samsung's SleepSense, Beurer's SE 80 Sleep Expert and the
Additionally, EarlySense won several awards and industry recognitions. Mattermark & Forbes listed EarlySense as one of the top 100 IOT startups in the world. FierceMedicalDevices named EarlySense a "Fierce 15" Med Tech Company of 2015, and Healthcare Informatics selected EarlySense as 2015 Up-and-Comer for Tracking Critical Patient Health Status.
"We look forward to introducing EarlySense's clinically validated technology to millions of homes, empowering consumers to improve their overall wellness, improve care for loved ones and enjoy the benefits of truly smart homes," added Halperin.
EarlySense is the market leader in contact-free and continuous monitoring for the medical and consumer wellness markets, with a unique sensor that is placed under the mattress and advanced analytics that leverage big data capabilities to provide unique offerings. The company's solutions monitor heart and respiratory rate, as well as movement and sleep. EarlySense's medical solutions for institution and home environments assist clinicians in early detection of patient deterioration and in identifying and preventing potential adverse events such as patient falls and pressure ulcers. EarlySense's wellness solutions facilitate personal wellness and sleep improvement and are a key part of smart home solutions. EarlySense also offers OEM solutions for companies looking to expand their products by providing contact-free and continuous sensing capabilities. The company's international headquarters are in Israel. The US headquarters are in Waltham, MA. The EarlySense Medical Systems are currently installed in hospitals and, rehabilitation centers and homes in USA, Europe, Asia and Australia.
For more information, visit http://www.EarlySense.com.
Follow us on Twitter.
Like us on Facebook.
(*)It is not possible to precisely determine the overall clinical and economic impact of implementing EarlySense systems globally. However, assuming that the outcome achieved in every bed is in line with the results published in the American Journal of Medicine in relation to reduction of adverse events are applicable worldwide, it is generally estimated that by early detection and intervention, clinicians were able to impact patients and hospitals as outlined herein.
Media Relations Contact: